Post BostonGene and the Parker Institute for Cancer Immunotherapy Collaborate to Generate Comprehensive Longitudinal Multi-Omic Data for Predicting Immunotherapy Outcomes
Post Researchers identify three-drug combination that helps curb the growth of deadly type of skin cancer
Post Parker Institute for Cancer Immunotherapy Scientists Present at ASCO 2018 on Gene Editing in Cell Therapy, Novel Checkpoint Inhibitor Combinations and Other Advances in Immuno-Oncology
Post PICI Makes Progress in Toughest Tumor Types with Pancreatic Cancer Combo, Immune Activity in Cold Tumors
Post Empowering Pancreatic Cancer Patients and Delivering Innovative Immunotherapies: 1440 Foundation